Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 56(23): 9418-26, 2013 Dec 12.
Article in English | MEDLINE | ID: mdl-24131491

ABSTRACT

A known limitation of iodine radionuclides for labeling and biological tracking of receptor targeted proteins is the tendency of iodotyrosine to rapidly diffuse from cells following endocytosis and lysosomal degradation. In contrast, radiometal-chelate complexes such as indium-111-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (In-111-DOTA) accumulate within target cells due to the residualizing properties of the polar, charged metal-chelate-amino acid adduct. Iodine radionuclides boast a diversity of nuclear properties and chemical means for incorporation, prompting efforts to covalently link radioiodine with residualizing molecules. Herein, we describe the Ugi-assisted synthesis of [I-125]HIP-DOTA, a 4-hydroxy-3-iodophenyl (HIP) derivative of DOTA, and demonstration of its residualizing properties in a murine xenograft model. Overall, this study displays the power of multicomponent synthesis to yield a versatile radioactive probe for antibodies across multiple therapeutic areas with potential applications in both preclinical biodistribution studies and clinical radioimmunotherapies.


Subject(s)
Antibodies, Monoclonal, Murine-Derived/metabolism , Dipeptides/chemical synthesis , Heterocyclic Compounds, 1-Ring/chemical synthesis , Immunoconjugates/chemistry , Succinimides/chemical synthesis , Animals , Antibodies, Monoclonal, Murine-Derived/chemistry , Antibodies, Monoclonal, Murine-Derived/therapeutic use , Coordination Complexes/metabolism , Dipeptides/metabolism , Heterocyclic Compounds, 1-Ring/metabolism , Immunoconjugates/metabolism , Indium Radioisotopes , Mice , Radioimmunotherapy , Succinimides/metabolism , Xenograft Model Antitumor Assays
2.
Neuron ; 74(3): 475-81, 2012 May 10.
Article in English | MEDLINE | ID: mdl-22578499

ABSTRACT

The lateral habenula (LHb) has recently been identified as a key regulator of the reward system by driving inhibition onto dopaminergic neurons. However, the nature and potential modulation of the major input to the LHb originating from the basal ganglia are poorly understood. Although the output of the basal ganglia is thought to be primarily inhibitory, here we show that transmission from the basal ganglia to the LHb is excitatory, glutamatergic, and suppressed by serotonin. Behaviorally, activation of this pathway is aversive, consistent with its role as an "antireward" signal. Our demonstration of an excitatory projection from the basal ganglia to the LHb explains how LHb-projecting basal ganglia neurons can have similar encoding properties as LHb neurons themselves. Our results also provide a link between antireward excitatory synapses and serotonin, a neuromodulator implicated in depression.


Subject(s)
Avoidance Learning/physiology , Basal Ganglia/physiology , Habenula/cytology , Neurons/drug effects , Serotonin/pharmacology , Animals , Animals, Newborn , Biophysics , Channelrhodopsins , Cholera Toxin/metabolism , Conditioning, Operant/physiology , Dopamine/pharmacology , Electric Stimulation , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Amino Acids/pharmacology , Glutamate Decarboxylase/metabolism , Habenula/physiology , Humans , In Vitro Techniques , Light , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Membrane Potentials/drug effects , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neural Pathways/physiology , Neurons/physiology , Optics and Photonics , Patch-Clamp Techniques , Quinoxalines/pharmacology , Rats , Rats, Sprague-Dawley , Time Factors , Transduction, Genetic/methods , Vesicular Glutamate Transport Protein 2/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...